Tao Gui
Overview
Explore the profile of Tao Gui including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
83
Citations
789
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Gui T, Luo L, Chhay B, Zhong L, Wei Y, Yao L, et al.
Biomaterials
. 2022 Mar;
283:121437.
PMID: 35247635
Oxidative stress and the reactive oxygen species (ROS) have important roles in osteoarthritis (OA) development and progression. Scavenging ROS by exogenous antioxidant enzymes could be a promising approach for OA...
22.
Wei Y, Ma X, Sun H, Gui T, Li J, Yao L, et al.
J Bone Miner Res
. 2022 Feb;
37(5):1012-1023.
PMID: 35191092
The uppermost superficial zone of articular cartilage is the first line of defense against the initiation of osteoarthritis (OA). We previously used Col2-Cre to demonstrate that epidermal growth factor receptor...
23.
Liu R, Tang W, Zheng B, Yang Y, Li Z, Gui T, et al.
Biochem Biophys Res Commun
. 2021 Dec;
590:20-26.
PMID: 34968780
Chondrosarcoma (CHS) is the second most common bone malignant tumor and currently has limited treatment options. We have recently demonstrated that thioredoxin interacting protein (TXNIP) plays a crucial role in...
24.
Yao B, Gui T, Zeng X, Deng Y, Wang Z, Wang Y, et al.
Genome Med
. 2021 Oct;
13(1):154.
PMID: 34607606
No abstract available.
25.
Cong S, Gui T, Shi Q, Zhang J, Feng J, Pan L, et al.
Sex Med
. 2021 Jul;
9(4):100390.
PMID: 34246178
Introduction: Female sexual arousal disorder (FSAD) is a common issue causing physical and psychological pain, but it has no standard diagnostic criteria or treatment. So its pathogenesis desiderates to be...
26.
Gui T, Liu M, Yao B, Jiang H, Yang D, Li Q, et al.
Cell Death Differ
. 2021 Jun;
28(12):3316-3328.
PMID: 34175897
Endometrial cancer (EC) is the most common gynecological malignancy worldwide. However, the molecular mechanisms underlying EC progression are still largely unknown, and chemotherapeutic options for EC patients are currently very...
27.
Wei Y, Sun H, Gui T, Yao L, Zhong L, Yu W, et al.
Elife
. 2021 Jun;
10.
PMID: 34085927
Meniscal tears are associated with a high risk of osteoarthritis but currently have no disease-modifying therapies. Using a Gli1 reporter line, we found that Gli1 cells contribute to the development...
28.
Yao B, Gui T, Zeng X, Deng Y, Wang Z, Wang Y, et al.
Genome Med
. 2021 Apr;
13(1):58.
PMID: 33853662
Background: Aberrant changes in epigenetic mechanisms such as histone modifications play an important role in cancer progression. PRMT1 which triggers asymmetric dimethylation of histone H4 on arginine 3 (H4R3me2a) is...
29.
Wei Y, Yan L, Luo L, Gui T, Jang B, Amirshaghaghi A, et al.
Sci Adv
. 2021 Apr;
7(15).
PMID: 33827816
Treating osteoarthritis (OA) remains a major clinical challenge. Despite recent advances in drug discovery and development, no disease-modifying drug for knee OA has emerged with any notable clinical success, in...
30.
Zhang H, Gui T, Liu R, Tong K, Wu C, Li Z, et al.
Cell Death Dis
. 2021 Jan;
12(1):121.
PMID: 33495462
Chondrosarcoma (CHS) is the second most common bone malignancy with limited therapeutic approaches. Our previous study has found that Yes associated protein 1 (YAP1) is downregulated in CHS cells treated...